Skin News and Research

RSS

Vitamin A improves insulin-producing beta-cells' function, study suggests

There has been no known link between diabetes and vitamin A - until now. A new study suggests that the vitamin improves the insulin producing β-cell´s function.

13 Jun 2017

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

Scientists have known for decades that smoking cigarettes causes DNA damage, which leads to lung cancer. Now, for the first time, UNC School of Medicine scientists created a method for effectively mapping that DNA damage at high resolution across the genome.

13 Jun 2017

Researchers pinpoint sugar modification in cells that spurs spread of skin cancer

A team of researchers has pinpointed a sugar modification in cells that spurs the spread of skin cancer. Its findings, which appear in the latest issue of the journal Cancer Cell, spotlight a target in the battle against melanoma.

13 Jun 2017

Study reveals role of mast cells in severe forms of dengue infection

Why mosquito-borne dengue virus causes more severe disease in some individuals, including hemorrhagic fever with or without shock, remains controversial and researchers are focusing on the factors related to the interaction between the virus and the host immune system, including the role of mast cells.

12 Jun 2017

Vegetarian diets found to be most effective for weight loss

Dieters who go vegetarian not only lose weight more effectively than those on conventional low-calorie diets but also improve their metabolism by reducing muscle fat, a new study published in the Journal of the American College of Nutrition has found.

12 Jun 2017

Tyson Foods Inc. recalls over 2 million pounds of chicken products

Tyson Foods Inc., a New Holland, Pa. establishment, has recalled more than 2.4 million pounds of their products containing ready-to-eat breaded chicken. The recall was announced by the U.S. Department of Agriculture's Food Safety and Inspection Service announced the recall on Friday, 9th of June. The Agency says that the label does not indicate the presence of milk which is a known allergen.

11 Jun 2017

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs

In an expanded, three-year clinical trial of 86 patients with colorectal and 11 other kinds of cancer that have so-called 'mismatch repair' genetic defects, scientists at Johns Hopkins Medicine and its Bloomberg~Kimmel Institute for Cancer Immunotherapy have found that half of the patients respond to an immunotherapy drug called pembrolizumab.

9 Jun 2017

Joslin Diabetes Center researchers establish CCTD to develop and translate cell-based interventions

Researchers and clinicians at Joslin Diabetes Center have established a Center for Cell-Based Therapy for Diabetes, the goal of which is to lead the development and translation of cell-based interventions to treat and cure diabetes and its complications.

9 Jun 2017

Without Measurement, There is No Control of Aseptic Processes

An interview with Gilberto Dalmaso, discussing the different grades of pharmaceutical cleanrooms and the production of high level compounds under aseptic conditions.

From Particle Measuring Systems 9 Jun 2017

Researchers who study HED identify mechanism that may be disrupted in male pattern baldness

It is almost axiomatic in medicine that the study of rare disorders informs the understanding of more common, widespread ailments.

8 Jun 2017

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

St. Jude Children's Research Hospital molecular biologists have identified an enzyme that activates and "supercharges" cellular machinery that controls how cells become specialized cells in the body.

7 Jun 2017

New protocol offers faster and more effective way to obtain astrocytes from stem cells

Neurons have long enjoyed the spotlight in neuroscience--and for good reason: they are incredibly important cellular actors. But, increasingly, star-shaped support cells called astrocytes are being seen as more than bit players in the brain's rich pageant.

6 Jun 2017

Studies offer hope for developing new biomarker and drug for neurodegenerative diseases

Two new studies of progressive, neurodegenerative diseases linked to defects in cells' mitochondria offer hope for developing a new biomarker for research and diagnostics, and a drug for treating such diseases, report researchers at the University of California, Davis.

6 Jun 2017

WHO releases list of antibiotics as last resort in superbug infections

This Tuesday (6th June 2017) the World Health Organization came out with a recommendation that some antibiotics should be kept in reserve as the last resort in superbug infections due to the risk of antibiotic resistance worldwide.

6 Jun 2017

Survey: More than 52% of people living with debilitating skin condition wait over four years for a diagnosis

To mark HS (hidradenitis suppurativa) Awareness Week from 5-11 June 2017, the Champions for Change campaign calls for people who suspect they may have HS to go and see their GP without delay.

6 Jun 2017

Stowers scientists provide evidence of cross-talk between Nanog and Hox genes

Competing regulatory genes "talk" to each other to maintain balance of cell state, according to new research from the Stowers Institute for Medical Research.

6 Jun 2017

Study reveals increased risk of ozone loss over the central United States during summer months

A new study out of Harvard University reveals that the protective stratospheric ozone layer above the central United States is vulnerable to erosion during the summer months from ozone-depleting chemical reactions, exposing people, livestock and crops to the harmful effects of UV radiation.

6 Jun 2017

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Findings from a phase III clinical trial point to a potential new treatment for patients newly diagnosed with advanced, epidermal growth factor receptor (EGFR)-positive non-small cell lung cancer (NSCLC).

5 Jun 2017

Novartis, Bristol-Myers Squibb collaborate to examine combination therapies for metastatic colorectal cancer

Novartis today announced it has entered into a clinical research collaboration in which Bristol-Myers Squibb will investigate the safety, tolerability, and efficacy of Mekinist (trametinib) in combination with Opdivo (nivolumab) and Opdivo + Yervoy (ipilimumab) regimen as a potential treatment option for metastatic colorectal cancer in patients with microsatellite stable tumors where the tumors are proficient in mismatch repair (MSS mCRC pMMR).

5 Jun 2017

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Findings from a study that looked at susceptibility trends of Staphylococcus aureus in U.S. hospital patients showed that key antibiotics used to treat the bacteria became more active over the course of the study, a rare occurrence.

5 Jun 2017

Skin News and Research

Vitamin A improves insulin-producing beta-cells' function, study suggests

Scientists create method for mapping genome-wide DNA damage caused by chemical carcinogen

Researchers pinpoint sugar modification in cells that spurs spread of skin cancer

Study reveals role of mast cells in severe forms of dengue infection

Vegetarian diets found to be most effective for weight loss

Tyson Foods Inc. recalls over 2 million pounds of chicken products

'Mismatch repair' genetic defects drive cancer patient's response to immunotherapy drugs

Joslin Diabetes Center researchers establish CCTD to develop and translate cell-based interventions

Without Measurement, There is No Control of Aseptic Processes

Researchers who study HED identify mechanism that may be disrupted in male pattern baldness

Molecular biologists identify enzyme that activates and ‘supercharges’ cellular machinery

New protocol offers faster and more effective way to obtain astrocytes from stem cells

Studies offer hope for developing new biomarker and drug for neurodegenerative diseases

WHO releases list of antibiotics as last resort in superbug infections

Survey: More than 52% of people living with debilitating skin condition wait over four years for a diagnosis

Stowers scientists provide evidence of cross-talk between Nanog and Hox genes

Study reveals increased risk of ozone loss over the central United States during summer months

Findings point to potential new treatment for people with newly diagnosed EGFR-positive NSCLC

Novartis, Bristol-Myers Squibb collaborate to examine combination therapies for metastatic colorectal cancer

Study finds increasing susceptibility of Staphylococcus aureus in U.S. hospital patients

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News